Clearleaf gotablanca cornell university fruit trials
SAN JOSÉ, Costa Rica — November 6, 2025: ClearLeaf announced major results from independent trials conducted by Cornell University's Cornell AgriTech, confirming that its flagship fungi-bactericide GotaBlanca delivers high-performance control of fungal and bacterial diseases in apples and grapes. The trials showed that GotaBlanca matched or outperformed conventional standards while maintaining an exceptional safety profile for crops and the environment.
In the apple trials, GotaBlanca demonstrated:
When incorporated into rotation programs, GotaBlanca matched or exceeded multi-product conventional programs with zero phytotoxicity across all applications.
“In our fire blight trials, GotaBlanca achieved 90% or greater control—surpassing streptomycin. Its performance in scab and powdery mildew rotation programs matched or exceeded conventional mixtures, while maintaining excellent crop health. The absence of phytotoxicity is a meaningful advantage for growers.”
In grape trials, GotaBlanca delivered:
“GotaBlanca showed versatility both as a standalone and rotation partner. Its performance on downy mildew surpassed grower standards, and black rot control was equivalent to systemic synthetics despite extremely high pressure. GotaBlanca integrates smoothly into IPM programs and supports sustainable viticulture.”
ClearLeaf’s CSO and Co-founder, Dr. Agustín Büchert, stated:
“These Cornell trials validate years of grower experience in Latin America. GotaBlanca matched or exceeded the disease control achieved by multi-product conventional programs using a single product. This reduces cost, chemical load, and operational complexity while delivering superior crop health and, in many cases, better yields.”
GotaBlanca is a broad-spectrum fungi-bactericide with a favorable safety and environmental profile. It aligns with regenerative agriculture practices and provides:
Regulatory Note: GotaBlanca is registered in select international markets. It is not currently registered for use or sale in the U.S. but EPA registration is planned.
